DNA microarray

DNA microarray. A DNA microarray is a high-throughput technology used to measure the expression levels of thousands of genes simultaneously or to genotype multiple regions of a genome. It consists of a solid surface, such as a glass slide or silicon chip, onto which microscopic spots of DNA sequences, known as probes, are attached in an ordered array. This tool revolutionized fields like functional genomics and pharmacogenomics by enabling the parallel analysis of vast amounts of genetic information, facilitating discoveries in areas ranging from cancer classification to evolutionary biology.

Principles and technology

The fundamental principle relies on the specific base pairing of complementary nucleic acid sequences through hydrogen bonding, a process central to techniques like the Southern blot. In a typical experiment, messenger RNA (mRNA) is extracted from biological samples, such as tumor tissue or yeast cultures, converted to complementary DNA (cDNA), and labeled with fluorescent dyes like Cy3 or Cy5. This labeled target is then hybridized to the array. Each probe spot corresponds to a specific gene or DNA sequence, and after washing, a laser scanner measures the fluorescence intensity at each spot. The intensity is proportional to the amount of target bound, thus quantifying the relative abundance of specific mRNA transcripts. The technology's development was pioneered by scientists including Stephen Fodor and teams at Stanford University.

Types and platforms

Several major platforms have been commercialized, primarily differing in how the DNA probes are synthesized and attached. **cDNA microarrays**, pioneered at Stanford University by Patrick O. Brown and others, use pre-synthesized cDNA probes, often several hundred base pairs long, spotted onto glass slides using a robotic arrayer. **Oligonucleotide microarrays**, such as those developed by Affymetrix (now part of Thermo Fisher Scientific), feature short, chemically synthesized probes directly built on a silicon wafer using photolithography, a technique adapted from the semiconductor industry. Another major platform from Agilent Technologies uses inkjet printing technology to synthesize longer oligonucleotides *in situ*. Specialized types include **tiling arrays** for genome-wide mapping and **single nucleotide polymorphism (SNP)** arrays from companies like Illumina, Inc. for genotyping and genome-wide association studies.

Applications in research

DNA microarrays have been instrumental across diverse biological and medical research domains. In functional genomics, they are used for gene expression profiling to compare tissues under different conditions, such as healthy versus diseased states in Alzheimer's disease or responses to drug treatments in pharmacogenomics. They have been critical in cancer research for molecular classification of tumors, identifying subtypes of leukemia and breast cancer with different prognoses, as demonstrated in studies by The Cancer Genome Atlas. In comparative genomics, arrays facilitate studies of evolution and biodiversity by comparing gene content across different species. Other applications include toxicogenomics for assessing chemical safety, microbiology for pathogen detection and strain identification, and epigenetics for profiling DNA methylation patterns.

Data analysis

The raw fluorescence data from a scanner generates large, complex datasets requiring sophisticated computational and statistical methods for interpretation. Initial steps involve **image analysis** to quantify spot intensities, followed by **data normalization** to correct for technical variations using algorithms like LOESS or quantile normalization. Statistical tests, such as the t-test or ANOVA, are then applied to identify genes with significant differential expression between sample groups, like treated versus control. Further analysis often employs techniques from bioinformatics and machine learning, including hierarchical clustering, principal component analysis (PCA), and support vector machines, to find patterns and classify samples. These analyses are supported by public databases like the Gene Expression Omnibus at the National Center for Biotechnology Information.

Advantages and limitations

The primary advantage is the ability to conduct highly parallel, genome-scale experiments, providing a broad, unbiased view of gene expression or genomic variation at a relatively low cost per data point. This high-throughput capacity accelerated discoveries in systems biology and personalized medicine. However, several limitations exist. The technology generally has a lower dynamic range and sensitivity for detecting very low-abundance transcripts compared to techniques like RNA-Seq. It is also a "closed" system, limited to interrogating only sequences for which probes are designed, unlike open next-generation sequencing methods. Cross-hybridization between similar sequences can cause false signals, and the data analysis requires significant expertise in statistics and computational biology. Despite these constraints, DNA microarrays remain a robust and widely used tool, especially for large-scale screening studies.